---
name: semaglutide-assessment
description: Use when asked to administer, score, or explain a Semaglutide Assessment — GLP-1 receptor agonist eligibility screening — grounded in FormExamples/form-examples.
---

# Semaglutide Assessment

GLP-1 receptor agonist eligibility screening for semaglutide therapy,
evaluating absolute/relative contraindications, metabolic profile, and
treatment planning.

## Scoring

**Instrument:** Eligibility Status — Eligible / Conditional /
Ineligible.

## What it covers

Demographics; indication and goals; body composition; metabolic
profile; cardiovascular risk; contraindications screening; GI history;
current medications; mental health screening; and treatment plan.

## Common pitfalls

- **Skipping GI history** — GLP-1 receptor agonists commonly cause GI
  side effects and are contraindicated or used cautiously in certain
  GI conditions (e.g. a history of pancreatitis, gastroparesis);
  omitting this section misses clinically important context.
- **Treating "Conditional" eligibility as a green light without
  addressing the condition** — the category implies a specific
  modification or monitoring requirement, not automatic approval to
  proceed unchanged.
- **Assessing eligibility without also screening mental health** — GLP-1
  therapy for weight management intersects with body image and eating
  behavior; the mental health screening section exists to catch
  relevant concerns before starting treatment.

## Learn more

- [FormExamples: semaglutide-assessment](https://github.com/FormExamples/form-examples/tree/main/forms/semaglutide-assessment) for the full implementation, clinical references, and worked examples.
- [[diabetes-assessment]] for a related metabolic assessment.